do glp 1 cause heart problems Early trials of GLP-1 based drugs have shown promising results in patients with failure with preserved ejection fraction., A new study in JAMA uses real-world evidence that complements these GLP-1RAs reduce cardiovascular deaths in

Therefore, this present review examines the cardiovascular effects of the GLP-1 RAs in T2D by revisiting the results of clinical studies evaluating CVD surrogate markers and cardiovascular events

Qsymia, a once-daily oral medication that is not a GLP-1 receptor agonist, is also indicated as an obesity treatment for adolescents aged 12-17

Who Tends to Maintain Weight Successfully After Stopping GLP-1s Patients who do best after discontinuation often share common factors: They taper slowly rather than stopping abruptly They rebuild hunger awareness while still on medication They prioritize adequate protein intake They preserve lean muscle through resistance training They address sleep, stress, and hormonal health They maintain medical follow-up during the transition This is not about perfection

GLP-1 weight loss programs provide access to glucagon-like peptide-1 receptor agonists through telehealth platforms

Invest in quality science journalism by making a donation to Science Friday